Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

FLAVOXATE IMPURITY A CRS (15 MG)

FLAVOXATE IMPURITY A CRS (15 MG)

NA

DISCOVER
FLAVOXATE IMPURITY B CRS (10 MG)

FLAVOXATE IMPURITY B CRS (10 MG)

NA

DISCOVER
PACLITAXEL SEMI-SYNTHETIC FORSYSTEM SUITABILITY CRS (1.01 M

PACLITAXEL SEMI-SYNTHETIC FORSYSTEM SUITABILITY CRS (1.01 M

33069-62-4

DISCOVER
ADRENALINE IMPURITY MIXTURE CRS (0.005 MG)

ADRENALINE IMPURITY MIXTURE CRS (0.005 MG)

NA

DISCOVER
ROPIVACAINE HYDROCHLORIDE MONOHYDRATE CRS (10 MG)

ROPIVACAINE HYDROCHLORIDE MONOHYDRATE CRS (10 MG)

132112-35-7

DISCOVER
ROPIVACAINE IMPURITY G CRS (5MG)

ROPIVACAINE IMPURITY G CRS (5MG)

NA

DISCOVER
DEXTRANOMER CRS (50 MG)

DEXTRANOMER CRS (50 MG)

NA

DISCOVER
MACROGOL 40 SORBITOL HEPTAOLEATE CRS (20 MG)

MACROGOL 40 SORBITOL HEPTAOLEATE CRS (20 MG)

NA

DISCOVER
INDINAVIR FOR SYSTEM SUITABILITY CRS (20 MG)

INDINAVIR FOR SYSTEM SUITABILITY CRS (20 MG)

157810-81-6

DISCOVER
MOXIDECTIN FOR SYSTEM SUITABILITY CRS (10 MG)

MOXIDECTIN FOR SYSTEM SUITABILITY CRS (10 MG)

113507-06-5

DISCOVER
Tibolone - reference spectrum, Qty : n/a

Tibolone - reference spectrum, Qty : n/a

NA

DISCOVER
ESSENTIAL OIL CRS (1000 MG)

ESSENTIAL OIL CRS (1000 MG)

NA

DISCOVER